Group One Trading
PASG icon

Group One Trading’s Passage Bio PASG Stock Holding History

Group One Trading’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-100
Closed -$6K – 8329
2022
Q1 		$6K Buy
+100
New +$8.24K ﹤0.01% 7392
2021
Q3 		– Sell
-15
Closed -$4K – 8624
2021
Q2 		$4K Buy
+15
New +$4.64K ﹤0.01% 7829

Other funds holding PASG

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
YCM
Yiheng Capital Management San Francisco, California $231M AUM 29.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Group One Trading's PASG Position: Q3 2025 in Review

Group One Trading sold out of Passage Bio (PASG) in Q3 2025, closing a stake of 2 shares — an estimated $14 sold.

Group One Trading first reported a position in PASG in Q1 2022 and held it in 14 quarters. The position peaked at $7K in Q1 2022. 32 funds tracked by Wall St. Rank hold PASG as of Q3 2025.

  • Group One Trading reported no remaining Passage Bio position as of Q3 2025 after selling out during the quarter.
  • Group One Trading sold 2 Passage Bio shares in Q3 2025, an estimated $14.
  • Group One Trading first reported a position in Passage Bio in Q1 2022 and held it in 14 quarters.
  • Group One Trading's Passage Bio position peaked at $7K in Q1 2022.
  • 32 funds tracked by Wall St. Rank held Passage Bio as of Q3 2025.

Based on Group One Trading's 13F filing for Q3 2025, filed 12 Nov 2025.